ROWEN STOKES: Open Payments
NPI 1659082667 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 25 payments from 10 companies in 2025. Trend: 2023 $52 · 2024 $147 · 2025 $1,163
Food & beverage: $1,068Education: $95
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 6 | $351 |
| Regeneron Healthcare Solutions, Inc. | 3 | $236 |
| ABBVIE INC. | 5 | $190 |
| Janssen Biotech, Inc. | 2 | $116 |
| UCB, Inc. | 2 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| LEO Pharma Inc. | 2 | $50 |
| GENZYME CORPORATION | 1 | $36 |
| Incyte Corporation | 1 | $29 |
| PFIZER INC. | 1 | $21 |
Products named: NEMLUVIO, DUPIXENT, RINVOQ, TREMFYA, Bimzelx, SKYRIZI, ADBRY, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
